Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    10397709 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
Conditions: Lymphoma;   Diffuse Large Cell
Intervention: Procedure: Blood draw
2 Active, not recruiting Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
Conditions: Lymphoma, Non-Hodgkin;   Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Ondansetron;   Drug: Dexamethasone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Drug: Ifosfamide;   Drug: Mesna (IV);   Drug: Mesna (oral);   Drug: Carboplatin;   Drug: Etoposide;   Drug: Rituximab;   Other: PET Scan

Indicates status has not been verified in more than two years